Company Number: 13776806

Analysis Date: 2025-07-20 15:09 UTC

Financial Health Assessment: SUBZERO PRODUCTIONS LIMITED

---

1. Financial Health Score: D

Explanation:
The company exhibits several symptoms of financial distress despite being operational and compliant with filing requirements. A very weak liquidity position and minimal net assets indicate financial fragility. The score "D" reflects concerns regarding sustainability if these trends persist without corrective action.

---

2. Key Vital Signs

Metric	2023 Value (£)	Interpretation
Fixed Assets	38,334	Stable but modest long-term asset base
Current Assets	8,204	Very low cash and short-term receivables
Current Liabilities	43,572	High short-term obligations
Net Current Assets (Working Capital)	-35,368	Significant negative working capital — a red flag ("liquidity distress")
Total Net Assets (Equity)	2,966	Very low equity cushion, declining from prior year
Average Number of Employees	4	Small workforce consistent with micro category

Interpretation:

• The negative working capital signals that the company currently owes much more in short-term debts than it holds in short-term assets, much like a patient with insufficient blood flow to vital organs—this is a liquidity crisis symptom.
• The net assets have declined by ~30% from £4,235 in 2022 to £2,966 in 2023, indicating the company is slowly eroding its equity base.
• Fixed assets are stable but modest, showing limited investment in long-term resources.
• The consistent employee count suggests steady operations but also limited scale.

---

3. Diagnosis

SUBZERO PRODUCTIONS LIMITED is showing clear symptoms of financial strain primarily due to poor liquidity management. The company operates in the take-away food sector, which typically demands strong cash flow management due to daily operational costs and supplier payments. However, with current liabilities exceeding current assets by a large margin, the company risks insolvency if it cannot meet short-term obligations promptly.

The low net asset base and declining equity suggest the business may be experiencing ongoing losses or drawing down reserves. This "symptom" resembles a patient whose vital organ functions are weakening, requiring immediate intervention.

Despite these financial issues, the company remains active, compliant with statutory filings, and has no overdue accounts or confirmation statements. The director and majority shareholder is actively involved, which is positive for governance and decision-making agility.

---

4. Recommendations

• Improve Liquidity:
  Prioritize improving cash flow by renegotiating payment terms with suppliers, accelerating receivables collections, or securing short-term financing. Consider tighter inventory control to free up working capital.

• Cost Control Measures:
  Review operational expenses thoroughly to cut non-essential costs. Evaluate staffing and overheads to ensure alignment with revenue generation capacity.

• Financial Planning and Forecasting:
  Implement robust cash flow forecasting to anticipate liquidity gaps and plan funding needs proactively.

• Equity Injection or Debt Restructuring:
  Explore capital injection from shareholders or restructuring existing debts to improve the balance sheet strength and reduce pressure on liquidity.

• Monitoring and Reporting:
  Increase financial monitoring frequency to detect early warning signs and take corrective actions promptly.

• Seek Professional Advice:
  Given the liquidity concerns, consulting with a financial advisor or insolvency practitioner may be prudent to explore all options for business recovery and sustainability.

---

Executive Summary